blog posts

• Unprecedented compound takes a step toward breast cancer clinical trials

  Nov 27, 2023 10:30 am by Jonathan KingInnovation
  • Share on Facebook
  • Tweet
  • Email

  

  Images

  • 

  TEQ103 targets estrogen receptor alpha (ERα) positive breast cancer cells and kills only the cells with an activated stress response, the so-called a-UPR. 

  stats

  additional actions
  • Share on Facebook
  • Tweet
  • Email